LAB
Standard BioTools, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.62
+0.85%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.02
- Revenue estimate
- $21.0M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- $0.03
- EPS estimate
- -$0.02
- Revenue actual
- $19.4M
- Revenue estimate
- $18.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +25.2%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | -$0.02 | $0.03 | Beat 250.00% | $19.4M |
| Aug 5, 2026 | -$0.01 | -$0.07 | Miss -449.02% | $20.1M |
| May 5, 2026 | -$0.02 | -$0.02 | In line | $21.1M |
| Feb 24, 2026 | -$0.03 | $0.06 | Beat 300.00% | $3.2M |
| Feb 26, 2025 | -$0.07 | -$0.05 | Beat 28.57% | $46.7M |
| Oct 30, 2024 | -$0.08 | -$0.05 | Beat 37.50% | $45.0M |
| Jul 31, 2024 | -$0.06 | -$0.08 | Miss -33.33% | $37.2M |
| Feb 28, 2024 | -$0.13 | -$0.08 | Beat 38.46% | $28.2M |
| Feb 14, 2023 | -$0.11 | -$0.19 | Miss -72.73% | $27.0M |
| May 5, 2022 | -$0.15 | -$0.25 | Miss -66.67% | $26.5M |
| Feb 17, 2022 | -$0.28 | -$0.12 | Beat 57.14% | $38.3M |
| Aug 5, 2021 | -$0.19 | -$0.23 | Miss -21.05% | $31.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027